TMTransMedics TMDX · NASDAQ
$70.78 -7.50% (-$5.74)
- Market cap
- $2.64B
- Enterprise value
- $3.04B
- P/E
- 17.4x
- Forward P/E
- 45.3x
- PEG
- 0.0x
- P/S
- 4.0x
- P/FCF
- 33.5x
- EV/EBITDA
- 25.3x
- ROIC
- 12.3%
- Bruto marža
- 58.7%
- Neto marža
- 22.7%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 3.3x
- Beta
- 1.93
- Free float
- 96.6%
O podjetju
TransMedics Group, Inc. (TMDX) is an American company specializing in the development and manufacturing of innovative medical devices for organ transplantation. With the aim of improving the preservation and transportation of organs intended for transplantation, TransMedics has developed the Organ Care System (OCS) technology. This technology allows organs to be maintained in optimal condition during transportation, potentially increasing the success of transplant procedures. The company is known for its commitment to saving lives and innovations in the field of organ transplantation. TransMedics Group, Inc. (TMDX) shares could be suitable for investors looking to invest in a company actively supporting medical research and life-saving through organ transplantation.
Sector
Healthcare
Industry
Medical - Devices
CEO
Waleed H. Hassanein
Employees
898
Headquarters
Andover
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke